MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African “meningitis belt”. In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to 29 years in the regions of Tillabéri, Niamey, and Dosso, in September and December 2010. We evaluated the campaign and determined which sub-populations or areas had low levels of vaccination coverage in the regions of Tillabéri and Niamey. After Phase I, conducted in the Filingué district, we estimated coverage using a 30×15 cluster-sampling survey and nested lot quality assurance (LQA) analysis in the clustered samples to identify which subpopulations (defined by age 1–14/15–29 and sex) had unacceptable vaccination coverage (<70%). After Phase II, we used Clustered Lot Quality Assurance Sampling (CLQAS) to assess if any of eight districts in Niamey and Tillabéri had unacceptable vaccination coverage (<75%) and estimated overall coverage. Estimated vaccination coverage was 77.4% (95%CI: 84.6–70.2) as documented by vaccination cards and 85.5% (95% CI: 79.7–91.2) considering verbal history of vaccination for Phase I; 81.5% (95%CI: 86.1–77.0) by card and 93.4% (95% CI: 91.0–95.9) by verbal history for Phase II. Based on vaccination cards, in Filingué, we identified both the male and female adult (age 15–29) subpopulations as not reaching 70% coverage; and we identified three (one in Tillabéri and two in Niamey) out of eight districts as not reaching 75% coverage confirmed by card. Combined use of LQA and cluster sampling was useful to estimate vaccination coverage and to identify pockets with unacceptable levels of coverage (adult population and three districts). Although overall vaccination coverage was satisfactory, we recommend continuing vaccination in the areas or sub-populations with low coverage and reinforcing the social mobilization of the adult population.
References
[1]
Greenwood B (1999) Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93: 341–353.
[2]
World Health Organization (WHO) (2010) Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Wkly Epidemiol Rec 85: 47–63.
[3]
WHO (1997) Response to epidemic meningitis in Africa, 1997. Wkly Epidemiol Rec 72: 313–318.
Thompson F (2011) End of a century-long scourge? Bull World Health Organ 89: 550–551. 10.2471/BLT.11.020811 [doi];BLT.11.020811 [pii].
[6]
LaForce FM, Okwo-Bele JM (2011) Eliminating epidemic group a meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood) 30: 1049–1057. 30/6/1049 [pii];10.1377/hlthaff.2011.0328 [doi].
[7]
WHO (2010) Global Advisory Committee on Vaccine Safety, report of meeting held 16–17 June 2010. Wkly Epidemiol Rec 84: 325–332.
[8]
World Health Organization (2005) Immunization coverage cluster survey - reference manual. Geneva: World Health Organization.
[9]
Hoshaw-Woodard S (2001) Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage.
[10]
World Health Organization (1996) Monitoring immunization services using the Lot Quality Technique. Geneva: World Health Organization.
[11]
WHO (2005) Immunization coverage cluster survey - reference manual. Geneva: World Health Organization.
[12]
Myatt M (2001) SampleLQ: a sample size calculator for community-based triage survey using lot quality assurance sampling. Brixton Health ICEH.
[13]
Lanata CF, Stroh G Jr, Black RE, Gonzales H (1990) An evaluation of lot quality assurance sampling to monitor and improve immunization coverage. Int J Epidemiol 19: 1086–1090.
[14]
Pezzoli L, Andrews N, Ronveaux O (2010) Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precision. Trop Med Int Health 15: 540–546. TMI2482 [pii];10.1111/j.1365-3156.2010.02482.x [doi].
[15]
Pezzoli L, Pineda S, Halkyer P, Crespo G, Andrews N, et al. (2009) Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007. Trop Med Int Health 14: 355–361. TMI2231 [pii];10.1111/j.1365-3156.2009.02231.x [doi].
[16]
Trotter CL, Gay NJ, Edmunds WJ (2005) Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 162: 89–100. 162/1/89 [pii];10.1093/aje/kwi160 [doi].
[17]
Stephens DS (2004) Herd Immunity from Meningococcal Serogroup C Conjugate Vaccination. Curr Infect Dis Rep 6: 351–352.
[18]
Stephens DS (2008) Vaccines for the unvaccinated: protecting the herd. J Infect Dis 197: 643–645. 10.1086/527402 [doi].
[19]
Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, et al. (2011) Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med 364: 2293–2304. 10.1056/NEJMoa1003812 [doi].
[20]
Haddad S, Bicaba A, Feletto M, Fournier P, Zunzunegui MV (2010) Heterogeneity in the validity of administrative-based estimates of immunization coverage across health districts in Burkina Faso: implications for measurement, monitoring and planning. Health Policy Plan 25: 393–405. czq007 [pii];10.1093/heapol/czq007 [doi].
[21]
Borgdorff MW, Walker GJ (1988) Estimating vaccination coverage: routine information or sample survey? J Trop Med Hyg 91: 35–42.
[22]
Zuber PL, Yameogo KR, Yameogo A, Otten MW Jr (2003) Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. J Infect Dis 187: Suppl 1S86–S90. JID020659 [pii];10.1086/368052 [doi].
[23]
Singh J, Jain DC, Sharma RS, Verghese T (1996) Evaluation of immunization coverage by lot quality assurance sampling compared with 30-cluster sampling in a primary health centre in India. Bull World Health Organ 74: 269–274.
[24]
Deitchler M, Valadez JJ, Egge K, Fernandez S, Hennigan M (2007) A field test of three LQAS designs to assess the prevalence of acute malnutrition. Int J Epidemiol 36: 858–864.
[25]
Greenland K, Rondy M, Chevez A, Sadozai N, Gasasira A, et al. (2011) Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage. Trop Med Int Health. 10.1111/j.1365-3156.2011.02770.x [doi].
[26]
Pezzoli L, Tchio R, Dzossa AD, Ndjomo S, Takeu A, et al. (2011) Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009. Epidemiol Infect 1–13. S0950268811000331 [pii];10.1017/S0950268811000331 [doi].
